Home > News > NanoLogix Study Confirms Early Success Of Hydrogen Bioreactor
May 9th, 2005
NanoLogix Study Confirms Early Success Of Hydrogen Bioreactor
Abstract:
NanoLogix, Inc., a Nanobiotechnology company engaged in the research, development and commercialization of technologies for the production of bacteria and disease testing kits, alternative sources of fuel, cancer therapy and remediation of toxic materials, announces that preliminary data and results of a study which confirms laboratory proof-of-concept measurements
have shown it possible to generate hydrogen in high yields via the use and adaptation of its intellectual property.
Source:
prnewswire
Bookmark:
Announcements
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013